Please login to the form below

Not currently logged in
Email:
Password:

genetic testing

This page shows the latest genetic testing news and features for those working in and with pharma, biotech and healthcare.

Alexion adds to pipeline with $1.2bn Syntimmune buy

Alexion adds to pipeline with $1.2bn Syntimmune buy

A lot of its efforts have been directed at bringing forward ravulizumab (ALXN1210), a Soliris follow-up with improved dosing frequency which has cleared phase 3 testing and is already submitted ... $855m, adding orally-active copper binder WTX-101 in

Latest news

  • FDA approves another home genetic testing service FDA approves another home genetic testing service

    FDA approves another home genetic testing service. 23andMe’s kit will check for an increased risk of certain cancers developing. ... The US Food and Drug Administration (FDA) has authorised another one of 23andMe’s home genetic kits, and this one

  • Lundbeck partners with 23andMe on first-of-its-kind study Lundbeck partners with 23andMe on first-of-its-kind study

    To this end, we expect the study to provide detailed insights into the interaction of mood symptoms, cognitive processes and environmental factors, and to link these factors to genetic data. ... changed its mind on 23andMe’s genetic testing kits.

  • FDA changes its mind on 23andMe's genetic testing kits FDA changes its mind on 23andMe's genetic testing kits

    FDA changes its mind on 23andMe's genetic testing kits. Approves a home test kit for gene sequences related to diseases like Alzheimer’s and Parkinson’s. ... what is expected to open the door for more direct-to-consumer (DTC) genetic test approvals.

  • EC approves Bial’s Parkinson’s disease therapy EC approves Bial’s Parkinson’s disease therapy

    Last year the Google-backed genetic testing company 23andMe signed a $60m research deal with Roche subsidiary Genentech to generate whole genome sequencing data for about 3, 000 people with

  • Roche buys gene sequencing firm Roche buys gene sequencing firm

    Roland Diggelmann, who is chief operating officer of Roche's diagnostics division, said adding Kapa to its portfolio would allow the company to offer "complete genetic testing" to its customers.

More from news
Approximately 3 fully matching, plus 30 partially matching documents found.

Latest Intelligence

  • Alnylam’s big moment: bringing groundbreaking RNAi drugs to Europe Alnylam’s big moment: bringing groundbreaking RNAi drugs to Europe

    In the US and Canada, the company has launched Alynlam Act, a free of charge genetic testing and counselling service. ... and for more of these genetic tests to be done.

  • Harnessing the power of genetics Harnessing the power of genetics

    Collaboration and data management offer huge potential for improving testing and analysis and the subsequent provision of advice to patients. ... Routine genetic testing and analytics should be made available to all who need it, harnessing the power of

  • 23andMe signs Parkinson’s deal with Genentech 23andMe signs Parkinson’s deal with Genentech

    23andMe signs Parkinson’ s deal with Genentech. Adds to list of pharma tie-ups for genetic testing firm. ... The Google-backed genetic testing company 23andMe has penned a new research pact with Roche subsidiary Genentech.

  • VIDEO interview: Neil Weir, UCB VIDEO interview: Neil Weir, UCB

    According to Dr Weir, if a patient is taught about the basis of his disease, he is more willing to collaborate on the research side, providing blood or genetic testing at ... According to Dr Weir, by understanding the genetic make-up of patients with the

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest appointments

  • MDxHealth creates new global commercial team MDxHealth creates new global commercial team

    Swansiger becomes senior vice president of business development at the biotechnology company and brings over 15 years of experience in oncology and autoimmune genomic and genetic testing. ... Rentrop joins from Noviogendix, where he was responsible for

  • Sophia Genetics names Marylin Mermod Schule as CFO Sophia Genetics names Marylin Mermod Schule as CFO

    Commenting on her appointment, Marylin Mermod Schule said: “ Sophia Genetics stands out among its peers in Europe in the rapidly growing field of genetic data analysis. “ ... The growth of precision medicine and increasing public interest in the

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OUTiCO

Providing an exceptional outsourcing service to the Pharma & Healthcare industries. We offer a sustainable approach and drive sales outcomes...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics